Oxidation and modification of extracellular matrix and its role in disease

被引:51
作者
Chuang, C. Y.
Degendorfer, G.
Davies, M. J.
机构
[1] Heart Res Inst, Newtown, Tas, Australia
[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
基金
澳大利亚研究理事会;
关键词
extracellular matrix; glycosaminoglycan; proteoglycan; protein oxidation; oxidative stress; peroxynitrous acid; myeloperoxidase; hypochlorous acid; radicals; metal ions; LOW-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC LESIONS; MUSCLE-CELL PROLIFERATION; CHONDROITIN SULFATE PROTEOGLYCAN; GLOMERULAR-BASEMENT-MEMBRANE; FIBROBLAST-GROWTH-FACTOR; ENDOTHELIAL GLYCOCALYX DISRUPTION; MYELOPEROXIDASE-DERIVED OXIDANTS; HYPOCHLORITE-MODIFIED PROTEINS; PEROXYNITRITE-MEDIATED DAMAGE;
D O I
10.3109/10715762.2014.920087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is accumulating evidence that damage to extracellular materials and particularly the extracellular matrix, can play a major role in multiple human pathologies. In contrast to cells, the extracellular compartment of most biological tissues is relatively poorly equipped to prevent or repair damage caused by oxidation due to lower levels of antioxidant defenses (low molecular mass and enzymatic) and repair systems (both catabolic and enzymatic). The extracellular compartment is therefore likely to be subject to both an increased extent of damage and an overall accumulation of damage due to slow turnover and/or poor repair. The nature and consequences of damage to the extracellular matrix is poorly understood, despite evidence that changes in matrix structure influences not only structural integrity, but also cell adhesion, proliferation, migration and signaling, and cytokine and growth factor binding. In this article the nature of the extracellular matrix is briefly reviewed, together with evidence for the presence of matrix modifications in cardiovascular disease. The oxidants and mechanisms that are known to damage extracellular matrix are reviewed, together with the limited data available to date on how such changes affect structural properties and cellular behavior.
引用
收藏
页码:970 / 989
页数:20
相关论文
共 193 条
[71]   Extracellular Matrix Proteoglycans are a Major Target for Peroxynitrite in the Artery Wall [J].
Kennett, Eleanor ;
Chuang, Christine Y. ;
Degendorfer, Georg ;
Rees, Martin D. ;
Hammer, Astrid ;
Malle, Ernst ;
Whitelock, John M. ;
Davies, Michael J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 :S113-S113
[72]   Degradation of extracellular matrix by peroxynitrite/peroxynitrous acid [J].
Kennett, Eleanor C. ;
Davies, Michael J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 (05) :716-725
[73]   Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: Evidence for a hydroxyl-radical-like mechanism [J].
Kennett, Eleanor C. ;
Davies, Michael J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (08) :1278-1289
[74]   Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains [J].
Kennett, Eleanor C. ;
Rees, Martin D. ;
Malle, Ernst ;
Hammer, Astrid ;
Whitelock, John M. ;
Davies, Michael J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (02) :282-293
[75]   Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen dioxide radicals in a site-selective manner: implications for peroxynitrite-mediated damage at sites of inflammation [J].
Kennett, Eleanor C. ;
Davies, Michael J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (04) :389-400
[76]   Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries [J].
Kinsella, MG ;
Irvin, C ;
Reidy, MA ;
Wight, TN .
ATHEROSCLEROSIS, 2004, 175 (01) :51-57
[77]   Changes in perlecan expression during vascular injury - Role in the inhibition of smooth muscle cell proliferation in the late lesion [J].
Kinsella, MG ;
Tran, PK ;
Weiser-Evans, MCM ;
Reidy, M ;
Majack, RA ;
Wight, TN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (04) :608-614
[78]  
KLEBANOFF SJ, 1993, AM J PATHOL, V143, P907
[79]   Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan [J].
Knox, S ;
Fosang, AJ ;
Last, K ;
Melrose, J ;
Whitelock, J .
FEBS LETTERS, 2005, 579 (22) :5019-5023
[80]   Differential accumulation of Proteoglycans and hyaluronan in culprit lesions - Insights into plaque erosion [J].
Kolodgie, FD ;
Burke, AP ;
Farb, A ;
Weber, DK ;
Kutys, R ;
Wight, TN ;
Virmani, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1642-1648